Toshihiro Nagato

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

Takayuki Ohkuri, Akemi Kosaka, Kei Ishibashi et al. · Cancer Immunology Immunotherapy · 2017 · 210 citations · Full text

Life Sciences, Immunology, Oncology +16

Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy

Toshihiro Nagato, Takayuki Ohkuri, Kenzo Ohara et al. · Cancer Immunology Immunotherapy · 2017 · 162 citations · Full text

Life Sciences, Immunology, Oncology +16

Combinatorial Immunotherapy of Polyinosinic–Polycytidylic Acid and Blockade of Programmed Death-Ligand 1 Induce Effective CD8 T-cell Responses against Established Tumors

Toshihiro Nagato, Young-Ran Lee, Yasuaki Harabuchi et al. · Clinical Cancer Research · 2014 · 101 citations · Full text

Medicine, Immunology, Oncology +17

Expression of Interleukin-9 in Nasal Natural Killer/T-Cell Lymphoma Cell Lines and Patients

Toshihiro Nagato, Hiroya Kobayashi, Kan Kishibe et al. · Clinical Cancer Research · 2005 · 87 citations · Full text

Life Sciences, Immunology, Oncology +9

CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma

Takumi Kumai, Toshihiro Nagato, Hiroya Kobayashi et al. · Cancer Immunology Immunotherapy · 2015 · 68 citations · Full text

Life Sciences, Immunology, Oncology +11